During the forecast period of 2021-2026, the Pediatric Clinical Trials Market is expected to develop at a CAGR of 14.5 percent

During the forecast period of 2021-2026, the Pediatric Clinical Trials Market is expected to develop at a CAGR of 14.5 percent. The outbreak of COVID-19 has an influence on the market for paediatric clinical trials. COVID-19 has an impact on the ability to enrol young patients for new trials and to keep registered patients on track with their study plans. Many clinical trials for COVID-19 vaccinations for children are currently underway, which is projected to considerably enhance market development. Pfizer Inc., for example, stated in June 2021 that it was moving on with Phase 2/3 clinical studies for young children in the United States at lower doses than vaccines for adults, for which it had begun enrolling participants. In June 2021, the Serum Institute of India (SII) applied to the Drug Controller and General of India (DCGI) for approval to conduct a clinical trial in the paediatric population for the Covovax COVID-19 vaccine. The market is predicted to rise as a result of these advancements.




Rising awareness of paediatric medicine, the outsourcing of in-house clinical trials to CROs, and the rising prevalence of paediatric diseases such as diabetes are projected to drive market expansion.

The pharmaceutical business has increasingly shifted from in-house clinical research to contract research organisations during the last decade (CRO).According to a paper on CRO strategic alliances published by Tufts University in cooperation with ICON PLC, it is anticipated that by 2020, 70% of all clinical trials will have been moved to CROs around the world. As CROs become more active in clinical research and are considered as calculated partners, giving access to not only specialised experts but also to patients all over the world, their position has grown in importance. Both the FDA and the European Medicines Agency (EMA) have made significant revisions to their standards, and most clinical studies now require a paediatric component..As the number of paediatric trials has increased, paediatric CROs have emerged, such as Paidion Research, the first worldwide CRO dedicated solely to paediatric health research. Many CROs are merging to raise their visibility and improve their offerings. Synteract, for example, purchased Pediatric CRO KinderPharm in November 2018 to bolster its paediatric development centre, which offers pharmacometric modelling and clinical trial simulation technology, as well as juvenile formulation and toxicology services. As a result of these advancements in CROs, in-house clinical trials are increasingly being outsourced to CROs.

Key Market Trends

Over the forecast period, the Oncology Segment Sub-segment Therepeutics Segmentation is expected to have a significant share.

Because of the rising prevalence of cancer in the paediatric age range, the oncology segment of the market researched is predicted to increase at an exponential rate over the projection period. Leukemia and brain and central nervous system malignancies are the most prevalent cancers in children under the age of 15. According to the American Cancer Society, in the year 2021, an estimated 10,500 children under the age of 15 would be diagnosed with cancer in the United States.It also claims that during the last few decades, the rate of paediatric cancer has risen. Furthermore, according to clinicaltrials.gov, there were around 3,287 ongoing paediatric cancer clinical trials in July 2021. The market is likely to develop as the number of these trials increases.

Comments

Post a Comment

Popular posts from this blog

One of the primary factors driving the Worldwide Frosting and Icing Market is the rising demand for cakes and pastries.

Image
  Market Dynamics The increased demand for cakes and pastries is one of the key reasons driving the global frosting and icing market . According to Agriculture and Agri-Food Canada, the value of cakes sold in the United Kingdom increased by an average of 2% every year from 2012 to 2017, outpacing the CAGR by 1.5 percent (2007-2012). Furthermore, an increase in the number of bakeries as a result of increased urbanisation and rising income, which leads to a burgeoning food sector, is fueling the expansion of the frosting and icing market. In 2015, India's food processing business was valued at US$ 258 billion, according to the India Brand Equity Foundation (IBEF), ranking fifth in terms of consumption, output, and exports. Health issues, such as increased obesity, are, however, restraining market growth. In 2017, 36.5 percent of adults in the United States were obese, according to the Centers for Disease Control and Prevention (CDC), which impeded market expansion. To tackle this, a ...
Read more

Orthopedic Power Tools Market predicted to be growing at a CAGR of 3.50 percent over the forecast period (2020-2027)

Image
Various orthopaedic illnesses in the musculoskeletal systems, such as musculoskeletal trauma, spine diseases, musculoskeletal injuries, and infections, are treated by orthopaedics. Orthopedic power tools are lightweight, user-friendly, and easy to handle when performing orthopaedic surgery when compared to traditional heavy orthopaedic tools. Electric powered orthopaedic tools, battery operated power systems, and pneumatic power tools are the three types of orthopaedic power tools. In 2020, the global orthopaedic power tools market is predicted to be worth US$ 943.8 million, growing at a CAGR of 3.50 percent over the forecast period (2020-2027). One of the reasons predicted to drive market expansion during the forecast period is the rising frequency of spinal injuries. According to a report issued by the National Spinal Cord Injury Statistical Center in 2018, the incidence of spinal cord injury in the United States is roughly 54 instances per one million individuals, with around 17,70...
Read more

The Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market will continue to increase as the number of ambulatory individuals seeking treatment for skin and skin structure infections rises

Image
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) are infections of the epidermis, dermis, and subcutaneous tissues that affect the skin and soft tissues. ABSSSI is defined by the US FDA as lesions having cellulitis/erysipelas, wound infections, and large cutaneous abscesses with a surface area of at least 75 cm2. ABSSSI is caused by pathogens such as Methicillin-sensitive Staphylococcus aureus (MSSA), Methicillin-resistant Staphylococcus aureus (MRSA), Beta-hemolytic Streptococcus, E. coli, Enterococcus faecalis, and Pseudomonas aeruginosa. The rising incidence of drug-resistant strains, particularly in Staphylococcus spp. and Enterococcus spp., makes this infection challenging to treat. The ABSSSI market is predicted to grow at a steady pace, thanks to an increasing number of patients suffering from these conditions and a significant number of pipeline treatments expected to be authorised during the forecast period. Acute Bacterial Skin and Skin Structure Infections (ABSSSI...
Read more